Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arni Jon Geirsson

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Spine Journal : Official Journal of the North American Spine Society|May 6, 2008
Rib cage motion in ankylosing spondylitis patients: a pilot studyMaria Ragnarsdottir, Arni Jon Geirsson, Bjorn Gudbjornsson
Annals of the Rheumatic Diseases|May 8, 2010
A strong familiality of ankylosing spondylitis through several generationsArni Jon Geirsson, Kristleifur Kristjansson, Bjorn Gudbjornsson
Laeknabladid|May 11, 2017
[Vanishing lungs - a case report]Thorunn Halldora Thordardottir, Arni Jon Geirsson, Sif Hansdottir
Psoriasis (Auckland, N.Z.)|May 17, 2018
Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registryBjorn Gudbjornsson, Arni Jon Geirsson, Niels Steen Krogh
Laeknabladid|April 13, 2017
[Tumors of unknown origin: Case report]Arni Jon Geirsson, Sigridur Thordis Valtysdottir, Andres Sigvaldason, et al.
Clinical and Experimental Rheumatology|April 22, 2010
Prevalence and clinical characteristics of ankylosing spondylitis in Iceland - a nationwide studyArni Jon Geirsson, Helga Eyjolfsdottir, Gyda Bjornsdottir, et al.
Laeknabladid|September 8, 2007
[Bone mineral density and bone turnover in systemic sclerosis]Bjarki Thor Alexandersson, Arni Jon Geirsson, Isleifur Olafsson, et al.
RMD Open|November 22, 2019
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritisUlf Lindström, Bente Glintborg, Daniela Di Giuseppe, et al.
Rheumatology (Oxford, England)|December 23, 2021
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registriesDaniela Di Giuseppe, Ulf Lindström, Kalle Aaltonen, et al.
Rheumatology (Oxford, England)|June 19, 2014
Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIOBente Glintborg, Bjorn Gudbjornsson, Niels Steen Krogh, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Spine Journal : Official Journal of the North American Spine Society|May 6, 2008
Rib cage motion in ankylosing spondylitis patients: a pilot studyMaria Ragnarsdottir, Arni Jon Geirsson, Bjorn Gudbjornsson
Annals of the Rheumatic Diseases|May 8, 2010
A strong familiality of ankylosing spondylitis through several generationsArni Jon Geirsson, Kristleifur Kristjansson, Bjorn Gudbjornsson
Laeknabladid|May 11, 2017
[Vanishing lungs - a case report]Thorunn Halldora Thordardottir, Arni Jon Geirsson, Sif Hansdottir
Psoriasis (Auckland, N.Z.)|May 17, 2018
Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registryBjorn Gudbjornsson, Arni Jon Geirsson, Niels Steen Krogh
Laeknabladid|April 13, 2017
[Tumors of unknown origin: Case report]Arni Jon Geirsson, Sigridur Thordis Valtysdottir, Andres Sigvaldason, et al.
Clinical and Experimental Rheumatology|April 22, 2010
Prevalence and clinical characteristics of ankylosing spondylitis in Iceland - a nationwide studyArni Jon Geirsson, Helga Eyjolfsdottir, Gyda Bjornsdottir, et al.
Laeknabladid|September 8, 2007
[Bone mineral density and bone turnover in systemic sclerosis]Bjarki Thor Alexandersson, Arni Jon Geirsson, Isleifur Olafsson, et al.
RMD Open|November 22, 2019
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritisUlf Lindström, Bente Glintborg, Daniela Di Giuseppe, et al.
Rheumatology (Oxford, England)|December 23, 2021
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registriesDaniela Di Giuseppe, Ulf Lindström, Kalle Aaltonen, et al.
Rheumatology (Oxford, England)|June 19, 2014
Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIOBente Glintborg, Bjorn Gudbjornsson, Niels Steen Krogh, et al.
Pageof 2